2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide

C106H85F3N24Pt4 — CID 161275745

About 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide

2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide (PubChem CID 161275745) has the molecular formula C106H85F3N24Pt4 and a molecular weight of 2532.32 g/mol. Its IUPAC name is 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide.

Molecular Properties

• Compound Name: 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
• PubChem CID: 161275745
• Molecular Formula: C106H85F3N24Pt4
• Molecular Weight: 2532.32 g/mol
• Exact Mass: 2530.59
• IUPAC Name: 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide
• SMILES: CCc1n[n-]c(-c2cccc(-c3cccc(-c4cccc(-c5[n-]nc(CC)c5C)n4)c3)n2)c1C.Cc1cc(-c2cccc(-c3cccc(-c4cccc(-c5cc(C(F)(F)F)n[n-]5)n4)c3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cccc(-c4cccc(-c5cc(C)n[n-]5)n4)c3)n2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1cc(-c2cccc(-c3[n-]nc4c3CCCC4)n2)cc(-c2cccc(-c3[n-]nc4c3CCCC4)n2)c1
• InChI: InChI=1S/C30H26N6.C28H26N6.C24H15F3N6.C24H18N6.4Pt/c1-3-12-25-21(10-1)29(35-33-25)27-16-6-14-23(31-27)19-8-5-9-20(18-19)24-15-7-17-28(32-24)30-22-11-2-4-13-26(22)34-36-30;1-5-21-17(3)27(33-31-21)25-14-8-12-23(29-25)19-10-7-11-20(16-19)24-13-9-15-26(30-24)28-18(4)22(6-2)32-34-28;1-14-11-21(31-30-14)19-9-3-7-17(28-19)15-5-2-6-16(12-15)18-8-4-10-20(29-18)22-13-23(33-32-22)24(25,26)27;1-15-12-23(29-27-15)21-10-4-8-19(25-21)17-6-3-7-18(14-17)20-9-5-11-22(26-20)24-13-16(2)28-30-24;;;;/h5-9,14-18H,1-4,10-13H2;7-16H,5-6H2,1-4H3;2-13H,1H3;3-14H,1-2H3;;;;/q4*-2;4*+2
• InChIKey: VEKOFAHWJRJOSA-UHFFFAOYSA-N
• XLogP: 20.83
• TPSA: 319.04 Ų
• H-Bond Acceptors: 16
• Rotatable Bonds: 18
• Heavy Atoms: 137
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2532.32
LogP ≤ 5	20.83
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	16

Frequently Asked Questions

What is the IUPAC name of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

The IUPAC name of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide (CID 161275745) is 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide.

What is the SMILES notation for 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

The canonical SMILES for 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide is CCc1n[n-]c(-c2cccc(-c3cccc(-c4cccc(-c5[n-]nc(CC)c5C)n4)c3)n2)c1C.Cc1cc(-c2cccc(-c3cccc(-c4cccc(-c5cc(C(F)(F)F)n[n-]5)n4)c3)n2)[n-]n1.Cc1cc(-c2cccc(-c3cccc(-c4cccc(-c5cc(C)n[n-]5)n4)c3)n2)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1cc(-c2cccc(-c3[n-]nc4c3CCCC4)n2)cc(-c2cccc(-c3[n-]nc4c3CCCC4)n2)c1.

What is the InChIKey of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

The InChIKey is VEKOFAHWJRJOSA-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H26N6.C28H26N6.C24H15F3N6.C24H18N6.4Pt/c1-3-12-25-21(10-1)29(35-33-25)27-16-6-14-23(31-27)19-8-5-9-20(18-19)24-15-7-17-28(32-24)30-22-11-2-4-13-26(22)34-36-30;1-5-21-17(3)27(33-31-21)25-14-8-12-23(29-25)19-10-7-11-20(16-19)24-13-9-15-26(30-24)28-18(4)22(6-2)32-34-28;1-14-11-21(31-30-14)19-9-3-7-17(28-19)15-5-2-6-16(12-15)18-8-4-10-20(29-18)22-13-23(33-32-22)24(25,26)27;1-15-12-23(29-27-15)21-10-4-8-19(25-21)17-6-3-7-18(14-17)20-9-5-11-22(26-20)24-13-16(2)28-30-24;;;;/h5-9,14-18H,1-4,10-13H2;7-16H,5-6H2,1-4H3;2-13H,1H3;3-14H,1-2H3;;;;/q4*-2;4*+2.

What are the key properties of 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide?

2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide has a molecular weight of 2532.32 g/mol, XLogP of 20.83, 18 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(5-ethyl-4-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-ethyl-4-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-(5-methylpyrazol-2-id-3-yl)-2-pyridinyl]phenyl]pyridine;2-(5-methylpyrazol-2-id-3-yl)-6-[3-[6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]-2-pyridinyl]phenyl]pyridine;tetrakis(platinum(2+));3-[6-[3-[6-(4,5,6,7-tetrahydroindazol-2-id-3-yl)-2-pyridinyl]phenyl]-2-pyridinyl]-4,5,6,7-tetrahydroindazol-2-ide is sourced from PubChem (CID 161275745), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).